254
views
views
Bioresorbable Vascular Scaffold Market
BVSs have been shown to be safe and effective in several clinical trials. The ABSORB trial, for example, demonstrated that Bioresorbable Vascular Scaffold was non-inferior to traditional metal stents in terms of safety and efficacy. The trial also showed that BVS reduced the rate of restenosis and improved clinical outcomes, with no increase in thrombotic events.
Read More: